#cancergrandchallenges
LightNews LightNews
cancergrand.bsky.social
🎧 Podcast feature: Prof. Kimmie Ng from #CancerGrandChallenges team #OPTIMISTICC on #Podnosis with @gliadkovskaya.bsky.social.

She explores the challenges of colorectal cancer rise in younger people.

▶️ www.fiercehealthcare.com/providers/ho...

#CancerResearch #ColorectalCancer #CancerInnovation
🎧 New podcast feature Prof. Kimmie Ng, from the Cancer Grand Challenges team OPTIMISTICC, was recently interviewed on Podnosis, the Fierce Healthcare podcast exploring the biggest trends and challenges shaping healthcare today. In the episode, Prof. Ng discusses why colorectal cancer rates are rising in younger people — including the role of diet, lifestyle, environmental exposures, obesity, and the microbiome. As part of OPTIMISTICC, her team is leading an international cohort study to better understand the mechanisms driving young-onset colorectal cancer. ▶️ Listen to the full podcast: https://www.fiercehealthcare.com/providers/how-doctors-are-rethinking-care-colorectal-cancer-shifts-younger #CancerGrandChallenges #CancerResearch #ColorectalCancer #GlobalHealth #HealthInnovation
February 5, 2026 at 2:34 PM
cancergrand.bsky.social
🎉 Congrats to #CancerGrandChallenges team members elected to the 2026 @theaacr.bsky.social Academy Fellows** 🎉

👏 Kimberly Stegmaier (PROTECT)
👏 Ben Cravatt (eDyNAmiC)
👏 Garry P. Nolan (STORMing)
👏 Anthony G. Letai #NCI

Honouring leaders advancing cancer research.
🔗 www.aacr.org/about-the-aa...
https://www.aacr.org/about-the-aacr/newsroom/news-releases/aacr-announces-fellows-of-the-aacr-academy-class-of-2026/
January 29, 2026 at 4:00 PM
cancergrand.bsky.social
Read about #CancerGrandChallenges Team #KOODAC’s innovative study, featured this week in @the-independent.com 👇
🔗 independent.co.uk/news/health/...

Funded through @cancergrand.bsky.social l by @cancerresearchuk.org , @institut-cancer.bsky.social & #Kika.

#CancerResearch #ImmunoOncology #MYC
Scientists may have found key to treating hidden cancer growths
Researchers say the findings offer a promising way to improve existing cancer therapies as well as develop new ones
independent.co.uk
January 29, 2026 at 3:43 PM
cancergrand.bsky.social
🧬 Not all cells in the same tissue behave the same. In skin, neighbouring cells can respond very differently to identical cancer.

🔗 www.cancergrandchallenges.org/news/tissue-...

#CancerResearch #TissueSpecificity #TeamScience
#CancerGrandChallenges SPECIFICANCER team, Future Leader Patricia P Centeno,
January 12, 2026 at 9:45 AM
cancergrand.bsky.social
🎟️ Register for the #CancerGrandChallenges conference – Cancer and the host

📝 Register now
📥 Abstract deadline 20 March
🗓️ 17–19 June 2026
📍@The Royal Society, London

🔗 cancergrandchallenges.org/conferences/cancer-and-the-host
January 6, 2026 at 9:29 AM
cancergrand.bsky.social
Researchers Nikolaos Sgourakis and John Maris from team NexTGen (co-funded by @themarkfdn.bsky.social) created a discovery system to identify new antigens in neuroblastoma.

📖 Read the Science Advances paper: doi.org/10.1126/scia...

#CancerResearch #neuroblastoma #CancerGrandChallenges
HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors
HLA-Shuttle enhances production of HLA class I molecules in neuroblastoma, leading to the discovery of tumor-associated antigens.
doi.org
January 5, 2026 at 1:26 PM
cancergrand.bsky.social
Register now for the #CancerGrandChallenges conference Spatial biology. A gathering of global leaders in research, technology, & clinical care.
📝 Register now
📥 Abstract deadline 15 May
🗓️ 1 - 3 September 2026
📍The Royal Society, London
🔗 cancergrandchallenges.org/conferences/spatial-biology
January 5, 2026 at 10:31 AM
cancergrand.bsky.social
The #CancerGrandChallenges impact reports reflect not just research milestones — but the power of global collaboration and visionary thinking to tackle some of cancer’s toughest challenges.

🔗 Explore the full impact reports here: lnkd.in/eGctd2rD

#CancerResearch #TeamScience
December 29, 2025 at 9:26 AM
cancergrand.bsky.social
What if we could spot #cancer before it strikes — or while it’s still treatable? A new study published in
@rsnasky.bsky.social is bringing us a step closer to that goal.

🔗 Read more doi.org/10.1148/radi...

Congratulations to Joseph Lo, Shelley Hwang and the #CancerGrandChallenges PRECISION team.
Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in SituRadiology
Mammographic radiomic features were able to predict occult invasive disease in core-needle biopsy–proven ductal carcinoma in situ in patients from three countries.
doi.org
December 3, 2025 at 2:09 PM
cancergrand.bsky.social
Read the newly published impact report from the SPECIFICANCER team that reshaped our understanding of tissue specificity.

Thanks to our co-funders, @themarkfdn.bsky.social, for supporting the #CancerGrandChallenges team and global science.

🔗 lnkd.in/eDrQ9guu
December 1, 2025 at 4:48 PM
cancergrand.bsky.social
🧬 Sponsor the #CancerGrandChallenges Spatial biology conference and join the community redefining how we see cancer.

Help accelerate the next generation of spatial approaches that could revolutionise cancer diagnosis and treatment.

Find out more: lnkd.in/e-7iZF6d
November 25, 2025 at 3:48 PM
cancergrand.bsky.social
We’re proud to share that 25 individuals from our international #CancerGrandChallenges community have been named among the @clarivate.com #highlycited2025.

To every awardee across our community congratulations, and thank you for your leadership and impact 👏. Read more ow.ly/y23050XohmV
Clarivate Highly Cited Researchers 2025
The Highly Cited Researchers 2025 list identifies and celebrates individuals who have demonstrated significant and broad influence in their fields of research. Through rigorous selection criteria and ...
ow.ly
November 17, 2025 at 1:37 PM
trishnadas.bsky.social
Honored to be part of this year’s Future Leaders’ Conference in Milan! Sharing science, hearing new ideas, and meeting inspiring people made it unforgettable. Thank you @cancergrand.bsky.social , #TeamCANCAN and Eileen White lab for this opportunity ✨

#CancerGrandChallenges #WomenInCachexia
November 16, 2025 at 6:26 PM
cancergrand.bsky.social
That’s a wrap for Future Leaders' Conference 2025!

This conference wasn’t just about sharing what’s been done—it was about igniting what comes next. The optimism and connections we witnessed will drive real progress in tackling some of the hardest questions in cancer #FLC25 #CancerGrandChallenges
November 14, 2025 at 5:08 PM
cancergrand.bsky.social
🔬 New research from #CancerGrandChallenges team PROSPECT explores possible links between diet and risk of bowel polyps in younger women.

🔗 Read more www.cancergrandchallenges.org/news/an-asso...
November 13, 2025 at 4:30 PM
cancergrand.bsky.social
“Take the most exciting options, take risks and be bold”

Words from Karen Vousden, Principal Group Leader at @crick.ac.uk and #CancerGrandChallenges Scientific Committee member, at day one of our Future Leaders’ Conference 2025 #FLC25
November 12, 2025 at 5:51 PM
cancergrand.bsky.social
Great to hear Iain Foulkes join @break-cancer.bsky.social's @boehmjesse.bsky.social, @su2c.bsky.social's Julian Adams & NUT Carcinoma Alliance's Maddie Musselman at @milkeninstitute.org #MIHealthSummit to discuss how global collaboration can drive innovation in cancer research #CancerGrandChallenges
November 7, 2025 at 3:49 PM
cancergrand.bsky.social
💡 New research from the #CancerGrandChallenges NexTGen team offers a way to make CAR T-cell therapy more effective — even against cancers that try to hide.

📖 Read the open-access paper in Nature Cancer: doi.org/10.1038/s43018-025-01056-4

#Immunotherapy #CART #PaediatricOncology #CancerResearch
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy - Nature Cancer
Majzner and colleagues show that engineering T cells with a membrane-tethered version of the signaling adaptor molecule SLP-76 alongside a chimeric antigen receptor (CAR) enhances CAR T cell activity ...
doi.org
November 7, 2025 at 2:12 PM
cancergrand.bsky.social
Discover is here — our annual progress magazine showcasing a year of extraordinary scientific breakthroughs from across the #CancerGrandChallenges community.

👉 Read the full magazine here: www.cancergrandchallenges.org/discover-a-y...
October 28, 2025 at 9:43 AM
cancergrand.bsky.social
We are thrilled that Charles Swanton, Chair of the #CancerGrandChallenges Scientific Committee, has been elected to the @nam.edu.

Please join us in congratulating Charlie on this prestigious and well-deserved honour 👏 #CancerResearch #TeamScience
nam.edu National Academy of Medicine @nam.edu · Oct 20
Congratulations and welcome to the 100 new members elected today to the National Academy of Medicine! #NAMmtg nam.edu/news-and-ins...
nam.edu
October 23, 2025 at 3:12 PM
natrevdrugdiscov.nature.com
Cancer cachexia contender enters first pivotal trial www.nature.com/articles/d41...

Can Pfizer’s appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help patients live longer in the process? Find out more in this news article #CancerGrandChallenges
Screenshot of story
October 10, 2025 at 2:22 PM
cancergrand.bsky.social
“If we can stop cachexia, we can help patients live better — and longer.” - Tobias Janowitz, Co-Lead of team CANCAN.

If you have access, discover how their work could change the way we treat one of cancer’s most overlooked challenges 👉 www.thetimes.com/uk/science/a... #CancerGrandChallenges
October 7, 2025 at 9:05 AM
cancergrand.bsky.social
#CancerGrandChallenges IMAXT in @nature.com:
Using CloneSeq-SV, the team tracked ovarian cancer clones and found:

• Resistant clones often exist from diagnosis
• ctDNA spotted recurrence ~8 months earlier than imaging
• Actionable drivers (e.g. ERBB2) can be revealed

www.nature.com/articles/s41...
October 3, 2025 at 12:35 PM
cancergrand.bsky.social
Targeted protein degraders could change how we treat childhood cancers.

John Buell of team KOODAC explains how our global team is working to develop safer, more effective therapies through #CancerGrandChallenges.

Find out more: koodac.com/scientific-e...
October 1, 2025 at 12:42 PM
idekerlab.bsky.social
We are very excited to be selected as a Cancer Grand Challenges finalist! Our Team 'Biologia Ex Machina' is developing the next generation of AI-powered co-scientists to revolutionize cancer research. Read more: today.ucsd.edu/story/uc-san... #CancerGrandChallenges #CGC
UC San Diego Researchers Shortlisted for International Cancer Competition
Twelve teams have reached the Cancer Grand Challenges finals, including two with UC San Diego scientists. Winners will receive up to £20 million to solve cancer's toughest problems.
today.ucsd.edu
September 30, 2025 at 5:05 PM